This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Novartis Ag. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Frank Hans Seiler: Innovator in Pharmaceutical Chemistry
Introduction
Frank Hans Seiler is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical biological pathways.
Latest Patents
Frank Hans Seiler holds two patents, both focusing on oxazolidin-2-one compounds. His latest inventions relate to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors. These compounds have potential applications in pharmaceutical compositions and methods for treating various conditions, diseases, and disorders that depend on PI3K.
Career Highlights
Seiler is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to explore innovative solutions in drug development and contribute to advancements in medical science.
Collaborations
Throughout his career, Frank Hans Seiler has collaborated with esteemed colleagues, including Giorgio Caravatti and Robin Alec Fairhurst. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Frank Hans Seiler's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the field. His work continues to influence the development of new therapeutic options for various medical conditions.